Items where Author is "Uhl, Martin"

Article

Seliger, Corinna and Meyer, Anne-Louise and Leidgens, Verena and Rauer, Lisa and Moeckel, Sylvia and Jachnik, Birgit and Proske, Judith and Dettmer, Katja and Rothhammer-Hampl, Tanja and Kaulen, Leon D. and Riemenschneider, Markus J. and Oefner, Peter J. and Kreutz, Marina and Schmidt, Nils-Ole and Merrill, Marsha and Uhl, Martin and Renner, Kathrin and Vollmann-Zwerenz, Arabel and Proescholdt, Martin and Hau, Peter (2022) Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23 (19): 11629. ISSN , 1422-0067

Weller, Johannes and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Brehmer, Stefanie and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Kebir, Sied and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. LANCET ONCOLOGY, 20 (10). pp. 1444-1453. ISSN 1470-2045, 1474-5488

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortmann, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Kowalski, Thomas and Ringel, Florian and Schmidt-Graf, Friederike and Suchorska, Bogdana and Brehmer, Stefanie and Weyerbrock, Astrid and Renovanz, Miriam and Bullinger, Lars and Galldiks, Norbert and Vajkoczy, Peter and Misch, Martin and Vatter, Hartmut and Stuplich, Moritz and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Schaub, Christina and Stummer, Walter and Tonn, Joerg-Christian and Simon, Matthias and Keil, Vera C. and Nelles, Michael and Urbach, Horst and Coenen, Martin and Wick, Wolfgang and Weller, Michael and Fimmers, Rolf and Schmid, Matthias and Hattingen, Elke and Pietsch, Torsten and Coch, Christoph and Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. LANCET, 393 (10172). pp. 678-688. ISSN 0140-6736, 1474-547X

Schaefer, Niklas and Proescholdt, Martin and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Grauer, Oliver and Goldbrunner, Roland and Friedrich, Franziska and Rohde, veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Grau, Stefan and Haenel, Mathias and Schnell, Oliver and Krex, Dietmar and Vajkoczy, Peter and Tabatabai, Ghazaleh and Mack, Frederic and Schaub, Christina and Tzaridis, Theophilos and Niessen, Michael and Kebir, Sied and Leutgeb, Barbara and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin and Herrlinger, Ulrich (2018) Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. NEURO-ONCOLOGY, 20 (7). pp. 975-985. ISSN 1522-8517, 1523-5866

Merkel, Andreas and Soeldner, Dorothea and Wendl, Christina and Urkan, Dilek and Kuramatsu, Joji B. and Seliger, Corinna and Proescholdt, Martin and Eyupoglu, Ilker Y. and Hau, Peter and Uhl, Martin (2017) Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials. JOURNAL OF NEURO-ONCOLOGY, 132 (2). pp. 249-254. ISSN 0167-594X, 1573-7373

Proske, Judith and Walter, Lisa and Bumes, Elisabeth and Hutterer, Markus and Vollmann-Zwerenz, Arabel and Eyuepoglu, Ilker Y. and Savaskan, Nicolai E. and Seliger, Corinna and Hau, Peter and Uhl, Martin (2016) Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma. ANTICANCER RESEARCH, 36 (3). pp. 899-905. ISSN 0250-7005, 1791-7530

Bumes, Elisabeth and Rzonsa, Sarah and Hutterer, Markus and Proescholdt, Martin and Bogdahn, Ulrich and Riemenschneider, Markus J. and Uhl, Martin and Wendl, Christina and Hau, Peter (2016) Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab. JOURNAL OF NEURO-ONCOLOGY, 127 (1). pp. 191-200. ISSN 0167-594X, 1573-7373

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Maciaczyk, Jaroslaw and Grau, Stefan and Schnell, Oliver and Haenel, Mathias and Krex, Dietmar and Vajkoczy, Peter and Gerlach, Ruediger and Kortmann, Rolf-Dieter and Mehdorn, Maximilian and Tuettenberg, Jochen and Mayer-Steinacker, Regine and Fietkau, Rainer and Brehmer, Stefanie and Mack, Frederic and Stuplich, Moritz and Kebir, Sied and Kohnen, Ralf and Dunkl, Elmar and Leutgeb, Barbara and Proescholdt, Martin and Pietsch, Torsten and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. JOURNAL OF CLINICAL ONCOLOGY, 34 (14). 1611-U134. ISSN 0732-183X, 1527-7755

Seliger, Corinna and Meyer, Anne-Louise and Renner, Kathrin and Leidgens, Verena and Moeckel, Sylvia and Jachnik, Birgit and Dettmer, Katja and Tischler, Ulrike and Gerthofer, Valeria and Rauer, Lisa and Uhl, Martin and Proescholdt, Martin and Bogdahn, Ulrich and Riemenschneider, Markus J. and Oefner, Peter J. and Kreutz, Marina and Vollmann-Zwerenz, Arabel and Hau, Peter (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-beta 2. CELL CYCLE, 15 (13). pp. 1755-1766. ISSN 1538-4101, 1551-4005

Seliger, Corinna and Meier, Christoph R. and Jick, Susan S. and Uhl, Martin and Bogdahn, Ulrich and Hau, Peter and Leitzmann, M. F. (2016) Use of cardiac glycosides and risk of glioma. JOURNAL OF NEURO-ONCOLOGY, 127 (2). pp. 321-328. ISSN 0167-594X, 1573-7373

Conference or Workshop Item

Weller, Johannes and Zeyen, Thomas and Schlegel, Uwe and Lazaridis, Lazaros and Werner, Jan-Michael and Onken, Julia and Zeiner, Pia and Drexler, Richard and Hau, Peter and Seidel, Clemens and Grosse, Lucia and Clusmann, Hans and Sabel, Michael and Ringel, Florian and Pichler, Josef and Grauer, Oliver and Hundsberger, Thomas and Schnell, Oliver and Mair, Maximilian J. and Uhl, Martin and Schmidt-Graf, Friederike and Glas, Martin and Galldiks, Norbert and Unteroberdoerster, Meike and Steinbach, Joachim and Ricklefs, Franz and Renovanz, Mirjam and Delev, Daniel Ivanov and Turgut, Merih O. and Flesch, Oliver R. and Cipriani, Debora and Preusser, Matthias and Kebir, Sied and Misch, Martin and Goldbrunner, Roland and Westphal, Manfred and Tabatabai, Ghazaleh and Schaefer, Niklas and Schneider, Matthias and Vatter, Hartmut and Giordano, Frank and Schaub, Christina and Herrlinger, Ulrich (2022) CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.

Other

Weller, Johannes and Tzaridis, Theophilos and Steinbach, Joachim and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Matthias, Schmid and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2018) QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.